RxDoctor Payments Data

Matthew Anderson, MD

Obstetrics & Gynecology · Tampa, FLNPI 1952482994

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $101,525 of the $136,022 with a category attached, or 74.6%. GSK accounts for 94.8% of it on its own, with 7 other manufacturers making up the rest. Among obstetrics & gynecology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$136,022in general payments, 2019–2025

Across 97 payments — averaging $1402.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$129K
  • Caris MPI, Inc.$4K
  • Intuitive Surgical$2K
  • AbbVie$253
  • Daiichi Sankyo Inc.$105
  • Johnson & Johnson$40
  • plus $44 from 2 others
$453,923in research payments, 2019–2025

Across 21 payments — averaging $21,615 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Caris MPI, Inc.$370K
  • Regeneron$58K
  • AstraZeneca$18K
  • Tesaro, Inc.$7K

What the payments were for

  • Consulting fees$18,57514%
  • Speaking & faculty fees$101,52575%
  • Travel & lodging$12,7689%
  • Food & beverage$3,1552%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$136,022 in reported general payments places this provider in the 95th percentile of 2,438 obstetrics & gynecology providers in Florida.

See all obstetrics & gynecology providers in Florida

Medicare billing

Part B allowed, 2024
$22,993
Medicare patients
60
Services billed
164

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ZejulaNiraparib Tosylate13$240,948
EliquisApixaban11$8,612
Gabapentin26$367
Oxycodone Hcl32$309
Fluconazole16$172

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKZejula$128,970$240,94813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,438 obstetrics & gynecology providers in Florida.

Other obstetrics & gynecology in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →